期刊文献+

人肝癌组织中血小板活化因子的表达及其临床意义

Expression and significance of platelet-activating factor in human hepatoceilular carcinoma
原文传递
导出
摘要 目的观察人肝癌组织血小板活化因子(PAF)的表达。方法应用免疫组织化学染色法检测PAF在10例晚期肝癌及其癌旁正常组织中的分布,逆转录-聚合酶链反应(RT—PCR)分析PAF受体mRNA表达水平。结果90%(9/10)的肝癌组织巾PAF受体mRNA和PAF表达增强,而癌旁组织中80%(8/10)PAF受体mRNA和PAF表达减少,两者差异有统计学意义(P〈0.05)。结论中晚期肝癌中PAF表达增强,可能存肝癌的发病过程中发挥重要作用。 Objective To investigate the expression of' platelet-activating factor (PAF) gene in human hepatocellular carcinoma (hHCC). Methods The samples were obtained from 10 cases of hHCC specimens. Immunohistochemistry and semi-quantitative RT-PCR techniques were used for detecting the PAF positive-staining and PAF receptor mRNA expression in 10 samples and adjacent noncanerous tissues. Results PAF positive-staining and PAF receptor mRNA were detected in 90% of hHCC samples and 20% adjacent noncanerous tissues respectively ( P 〈0. 05 ). Conclusion The PAF expression is increased in middle - advance hHCC,which may play a role in the pathogenesis of hHCC.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第9期1142-1143,共2页 Chinese Journal of Experimental Surgery
关键词 肝细胞 血小板活化因子 Carcinoma,hepatocellular PAF
  • 相关文献

参考文献1

二级参考文献39

  • 1[35]Shirasaki H,Adcock IM,Kwon OJ,Nishikawa M,Mak JC,Barnes PJ.Agonist-induced up-regulation of platelet-activating factor receptor messenger RNA in human monocytes.Eur J Pharmacol 1994; 268:263-266
  • 2[36]Bedossa P,Peltier E,Terris B,Franco D,Poynard T.Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal,cirrhotic,and neoplastic human livers.Hepatology 1995; 21:760-766
  • 3[37]Sato S,Kume K,Takan T,Mutoh H,Taketani Y,Shimizu T.Up-regulation of the intracellular Ca2+ signaling and mRNA expression of platelet-activating factor receptor by estradiol in human uterine endometrial cells.Adv Exp Med Biol 1996; 416:95-100
  • 4[38]Castagnetta LA,Agostara B,Montalto G,Polito L,Campisi I,Saetta A,Itoh T,Yu B,Chen S,Carruba G.Local estrogen formation by nontumoral,cirrhotic,and malignant human liver tissues and cells.Cancer Res 2003; 63:5041-5045
  • 5[39]Seo KH,Lee HS,Jung B,Ko HM,Choi JH,Park SJ,Choi IH,Lee HK,Im SY.Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.Cancer Res 2004; 64:6482-6488
  • 6[1]Denizot Y,Guglielmi L,Donnard M,Trimoreau F.Plateletactivating factor and normal or leukaemic haematopoiesis.Leuk Lymphoma 2003; 44:775-782
  • 7[2]Arai H,Koizumi H,Aoki J,Inoue K.Platelet-activating factor acetylhydrolase (PAF-AH).J Biochem (Tokyo) 2002; 131:635-640
  • 8[3]Izumi T,Shimizu T.Platelet-activating factor receptor:gene expression and signal transduction.Biochim Biophys Acta 1995;1259:317-333
  • 9[4]Mustafa SB,Flickinger BD,Olson MS.Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells.Hepatology 1999; 30:1206-1214
  • 10[5]Sakaguchi T,Nakamura S,Suzuki S,Oda T,Ichiyama A,Baba S,Okamoto T.Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats.Hepatology 1999; 30:959-967

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部